DBT and Assam Govt Sign MoU Under BioE3 Policy to Strengthen Centre-State Partnership in Biotechnology

The MoU signing ceremony took place at DBT Headquarters, New Delhi, with key dignitaries in attendance. (Photo Source: @DBTIndia/X) In a major push for India’s biotechnology sector, Department of Biotechnology (DBT), and the Assam Government have …

Unity Biotechnology Inc appoints Yehia Hashad, MD, to the board of directors and science committee

Yehia Hashad, MD, has been appointed to the board of directors and as a member of its science committee for Unity Biotechnology Inc. In the company’s press release1, Anirvan Ghosh, PhD, chief executive officer of UNITY Biotechnology spoke to Hashad’s …

Uzbekistan studies Singapore’s experience in biotechnology and regenerative medicine

During their stay in Singapore, the delegation held talks at leading scientific and medical institutions such as the National University Cancer Institute of Singapore (NCIS), the National University Health System (NUHS), and the Advanced Cell Therapy and …

"Increasing biodiversity starts with local breeding programs supported by biotechnology"

"Our organization was founded and held its first meeting in Bonn in 1993 with the participation of representatives from Germany, France, the Netherlands, the United Kingdom, Switzerland, Belgium, Denmark, Greece, and Italy. Since then, many other …

DBT and Assam govt sign MoU on biotechnology

In a step towards fostering sustainable biotechnology and high-performance biomanufacturing, the Department of Biotechnology (DBT) and the Government of Assam have signed a Memorandum of Understanding (MoU) under the BioE3 (Biotechnology for Economy, …

Dept of Biotechnology and Govt of Assam Signs MoU for Centre-State Partnership under BioE3 Policy

NZAS Supports Saving Biotechnology Capacity In Callaghan; Asks What Now For Applied Technology Group

The New Zealand Association of Scientists (NZAS) Co-Presidents applaud Science Innovation and Technology Minister Dr Shane Reti’s announcement today that two groups of scientists at Callaghan Innovation have been given a lifeline. The Biotechnology group …

Five Biotechnology Teams Saved At Callaghan Innovation, But Hundreds Of Redundancies Still Expected

Press Release – PSA “This whole approach has been clumsy from the get-go with job cuts last year coming ahead of the science system reform plan this year, causing unnecessary distress and uncertainty for many Callaghan workers and their families.” Some …

New KIF18A inhibitors disclosed in Shanghai Apeiron Biotechnology patent

Cancer Shanghai Apeiron Biotechnology Co. Ltd. has divulged kinesin-like protein KIF18A inhibitors reported to be useful for the treatment of cancer, inflammatory disorders and Kartagener syndrome (primary ciliary dyskinesia). BioWorld Science Cancer …

An Innovative Funding Model for Biotechnology Companies (Webcast Recap)

Many early stage biotechnology companies face challenges in securing funding. The biotechnology sector is highly competitive, and capital has been scarce in the last few years, leading some companies to seek alternative collaboration opportunities. In a …